Limitation of myocardial and endothelial injury of the rat heart graft after preservation with Centre de Résonance Magnétique Biologique et Médicale (CRMB) solution

Transplant International

Volumn 21, Issue 3, 2008, Pages 276-283

  Desrois, Martine ^a,d   Caus, Thierry ^a,b   Belles, Pablo Marin ^a,c   Dalmasso, Christiane ^a   Lan, Carole ^a   Cozzone, Patrick J ^a   Bernard, Monique ^a  

^a CNRS   (France)

^b AMIENS UNIVERSITY HOSPITAL   (France)

^c NONE

^d University of Aix Marseille   (France)

Author keywords

Endothelium; Heart; Ischaemia reperfusion; Nitric oxide; Preservation; Transplantation

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE TRIPHOSPHATE; CELSIOR; CREATINE PHOSPHATE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLD ISCHEMIA; CONTROLLED STUDY; ENDOTHELIUM INJURY; HEART FUNCTION; HEART GRAFT; HEART MUSCLE INJURY; HEART MUSCLE REPERFUSION; HEART RATE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; DISACCHARIDES; ELECTROLYTES; ENDOTHELIUM, VASCULAR; GLUTAMATES; GLUTATHIONE; HEART TRANSPLANTATION; HISTIDINE; MANNITOL; NITRIC OXIDE; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; PHOSPHOCREATINE; RATS; RATS, INBRED LEW; REPERFUSION; TRANSPLANTATION, ISOGENEIC;

EID: 38849140931     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2007.00602.x     Document Type: Article

References (46)

1. Stoica SC, Goddard M, Large SR. The endothelium in clinical cardiac transplantation. Ann Thorac Surg 2002 73 : 1002.
2. Beyersdorf F. Myocardial and endothelial protection for heart transplantation in the new millenium: lessons learned and future directions. J Heart Lung Transplant 2004 23 : 657.
3. Amrani M, Yacoub MH. Endothelial function in myocardial protection. Curr Opin Cardiol 1996 11 : 559.
4. Podesser BK, Hallström S. Nitric oxide homeostasis as a target for drug additives to cardioplegia. Br J Pharmacol 2007 151 : 930.
5. Valantine HA. Cardiac allograft vasculopathy: central role of endothelial injury leading to transplant "atheroma". Transplantation 2003 76 : 891.
6. Moens AL, Claeys MJ, Timmermans JP, Vrints CJ. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int J Cardiol 2005 100 : 179.
7. Wang QD, Pernow J, Sjoquist PO, Ryden L. Pharmacological possibilities for protection against myocardial reperfusion injury. Cardiovasc Res 2002 55 : 25.
8. Bernard M, Caus T, Sciaky M, Lan C, Cozzone PJ. Optimized cardiac graft preservation: a comparative experimental study using P-31 magnetic resonance spectroscopy and biochemical analyses. J Heart Lung Transplant 1999 18 : 572.
9. Caus T, Desrois M, Izquierdo M, et al. NOS substrate during cardioplegic arrest and cold storage decreases stunning after heart transplantation in a rat model. J Heart Lung Transplant 2003 22 : 184.
10. Desrois M, Sciaky M, Lan C, Cozzone PJ, Bernard M. Metabolic and functional effects of low-potassium cardioplegic solutions for long term heart preservation. Magn Reson Mater Phy (MAGMA) 1999 8 : 77.
11. Desrois M, Sciaky M, Lan C, Cozzone PJ, Bernard M. l-arginine during long-term ischemia: effects on cardiac function, energetic metabolism and endothelial damage. J Heart Lung Transplant 2000 19 : 367.
12. Desrois M, Caus T, Lan C, Sciaky M, Cozzone PJ, Bernard M. Comparative effects of Celsior and a new cardioplegic solution on function, energy metabolism and intracellular pH during long-term heart preservation. Transplant Proc 2002 34 : 1259.
13. Kevelaitis E, Berg Nyborg NC, Menasché P. Coronary endothelial dysfunction of isolated hearts subjected to prolonged cold storage: patterns and contributing factors. J Heart Lung Transplant 1999 18 : 239.
14. Caus T, Izquierdo M, Lan C, et al. Simultaneous study of metabolism and function following cardioplegic arrest: a novel method of evaluation of the transplanted heart in the rat. J Heart Lung Transplant 2001 20 : 575.
15. Desrois M, Durrans A, Caus T, et al. Modulation of the NO pathway during short or prolonged blood reperfusion following ischaemia in a heterotopic rat heart transplantation model. Transplant Proc 2004 36 : 1280.
16. Bernard M, Robert K, Caus T, et al. Protective effect of a low K+ cardioplegic solution on myocardial Na,K-ATPase activity. Cell Mol Biol (Noisy-le-grand) 2004 50 : 841.
17. Gill RM, Braz JC, Jin N, Etgen GJ, Shen W. Restoration of impaired endothelium-dependent coronary vasodilation in failing heart: role of eNOS phosphorylation and CGMP/cGK-I signaling. Am J Physiol Heart Circ Physiol 2007 292 : H2782.
18. 2+) loading and adrenergic stimulation reveal male/female differences in susceptibility to ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2002 283 : H481.
19. Desrois M, Caus T, Belles PM, et al. Nitric oxide pathway after long-term cold storage and reperfusion in a heterotopic rat heart transplantation model. Transplant Proc 2005 37 : 4553.
20. McGowan FX, Cao-Danh H, Takeuchi K, Davis PJ, del Nido PJ. Prolonged neonatal myocardial preservation with a highly buffered low-calcium solution. J Thorac Cardiovasc Surg 1994 108 : 772.
21. Takeuchi K, Buenaventura P, Cao-Danh H, et al. Improved protection of the hypertrophied left ventricle by histidine-containing cardioplegia. Circulation 1995 92 : II395.
22. Peart JN, Headrick JP. Adenosinergic cardioprotection: multiple receptors, multiple pathways. Pharmacol Ther 2007 114 : 208.
23. Mubagwa K, Flameng W. Adenosine, adenosine receptors and myocardial protection: an updated overview. Cardiovasc Res 2001 52 : 25.
24. Manintveld OC, te Lintel Hekkert M, Keijzer E, Verdouw PD, Duncker DJ. Intravenous adenosine protects the myocardium primarily by activation of a neurogenic pathway. Br J Pharmacol 2005 145 : 703.
25. 2+ overload in ischemia-reperfused heart and hypoxia-reoxygenated cardiomyocytes. Eur J Pharmacol 2006 535 : 212.
26. Fenster BE, Tsao PS, Rockson SG. Endothelial dysfunction: clinical strategies for treating oxidant stress. Am Heart J 2003 146 : 218.
27. Chan BBK, Kron IL, Flanagan TL, Kern JA, Hobson CE, Tribble CG. Impairment of vascular endothelial function by high-potassium storage solutions. Ann Thorac Surg 1993 55 : 940.
28. Mankad PS, Chester AH, Yacoub MH. Role of potassium concentration in cardioplegic solutions in mediating endothelial damage. Ann Thorac Surg 1991 51 : 89.
29. Colagrande L, Formica F, Porta F, et al. Reduced cytokines release and myocardial damage in coronary artery bypass patients due to l-arginine cardioplegia supplementation. Ann Thorac Surg 2006 81 : 1256.
30. Kiziltepe U, Tunctan B, Eyileten ZB, et al. Efficiency of l-arginine enriched cardioplegia and non-cardioplegic reperfusion in ischemic hearts. Int J Cardiol 2004 97 : 93.
31. Carrier M, Pellerin M, Perrault LP, et al. Cardioplegic arrest with l-arginine improves myocardial protection: results of a prospective randomized clinical trial. Ann Thorac Surg 2002 73 : 837.
32. Bode-Böger SM, Scalera F, Ignarro LJ. The l-arginine paradox: importance of the l-arginine/asymmetrical dimethylarginine ratio. Pharmacol Ther 2007 114 : 295.
33. Vukosavljevic N, Jaron D, Barbee KA, Buerk DG. Quantifying the l-arginine paradox in vivo. Microvasc Res 2006 71 : 48.
34. Tsikas D, Boger RH, Sandmann J, Bode-Boger SM, Frolich JC. Endogenous nitric oxide synthase inhibitors are responsible for the l-arginine paradox. FEBS Lett 2000 478 : 1.
35. Hardy TA, May JM. Coordinate regulation of l-arginine uptake and nitric oxide synthase activity in cultured endothelial cells. Free Radic Biol Med 2002 32 : 122.
36. McDonald KK, Zharikov S, Block ER, Kilberg MS. A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the "arginine paradox". J Biol Chem 1997 272 : 31213.
37. Joshi MS, Ferguson TB Jr., Johnson FK, Johnson RA, Parthasarathy S, Lancaster JR Jr. Receptor-mediated activation of nitric oxide synthesis by arginine in endothelial cells. Proc Natl Acad Sci USA 2007 104 : 9982.
38. Pisarenko OI, Oleynikov OD, Shulzhenko VS, Studneva IM, Ryff IM, Kapelko VI. Association of myocardial glutamate and aspartate pool and functional recovery of postischemic heart. Biochem Med Metab Biol 1989 42 : 105.
39. Pisarenko OI, Solomatina ES, Studneva IM, Ivanov VE, Kapelko VI, Smirnov VN. Effect of glutamic and aspartic acids on adenine nucleotides, nitrogenous compounds and contractile function during underperfusion of isolated rat heart. J Mol Cell Cardiol 1983 15 : 53.
40. Bernard M, Menasche P, Canioni P, et al. Influence of the pH of cardioplegic solution on intracellular pH, high energy phosphates and post arrest performance. Protective effect of acidotic, glutamate-containing cardioplegic perfusates. J Thorac Cardiovasc Surg 1985 90 : 235.
41. Desrois M, Sciaky M, Lan C, Cozzone PJ, Bernard M. Preservation of amino acids during long term ischaemia and subsequent reflow with supplementation of l-arginine, the nitric oxide precursor, in the rat heart. Amino Acids 2003 24 : 141.
42. Hallström S, Gasser H, Neumayer C, et al. S-nitroso human serum albumin treatment reduces ischemia/reperfusion injury in skeletal muscle via nitric oxide release. Circulation 2002 105 : 3032.
43. Huk I, Nanobashvili J, Neumayer C, et al. l-arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle. Circulation 1997 96 : 667.
44. Xuan YT, Tang XL, Qiu Y, et al. Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits. Am J Physiol Heart Circ Physiol 2000 279 : H2360.
45. Wildhirt SM, Weiss M, Schulze C, et al. Myocardial preservation in clinical cardiac transplantation. Transplant Proc 1999 31 : 147.
46. Koch A, Burgschweiger A, Herpel E, et al. Inducible NO synthase expression in endomyocardial biopsies after heart transplantation in relation to the postoperative course. Eur J Cardiothorac Surg 2007 32 : 639.